OPTN OptiNose

Watchlist

6.000
+0.380+6.76%

Close Feb 14 16:00 ET

60.33MMarket Cap-1.38P/E (TTM)

About OptiNose Company

OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.

Company Profile

SymbolOPTN

Company NameOptiNose

Listing DateOct 13, 2017

Issue Price16.00

Founded2000

CEODr. Ramy A. Mahmoud, M.D.

MarketNASDAQ

Employees132

Fiscal Year Ends12-31

Address777 Township Line Road,Suite 300

CityYardley

ProvincePennsylvania

CountryUnited States of America

Zip Code19067

Phone1-267-364-3500

Websitehttp://www.optinose.com

Company Executives

Name
Position
Salary

Dr. Ramy A. Mahmoud, M.D.
Chief Executive Officer and Director
2.41M

Anthony J. Krick
Vice President, Finance and Chief Accounting Officer
--

Paul Spence, Jr
Chief Commercial Officer
664.02K

P. Terence Kohler, Jr
Chief Financial Officer
--

Michael F. Marino, III,
Chief Legal Officer and Corporate Secretary
1.32M

R. John Fletcher
Chairman of the Board
120.22K

Dr. Eric Bednarski
Independent Director
88.42K

Sandra L. Helton
Independent Director
103.42K

Tomas J. Heyman
Independent Director
96.88K

Kyle Dempsey
Independent Director
90.92K

Wilhelmus C. M. Groenhuysen
Independent Director
100.92K

OPTN OptiNose

About OptiNose Company

Company Profile

Company Executives

Trending Stocks